Advertisement
Financing › Details
Therachon–France (govt): investment, 201905 existing investors Bpifrance + Inserm Transfert Initiative
Period | 2019-05-08 � 2019-05-08 | |
Successor | Therachon–Pfizer: investment, 201905–201907 acquisition 100% $340m upfront + $470m milestones excl apraglutide development program | |
Money taker | Therachon Holding AG | |
Group | Pfizer (Group) | |
Money source | Inserm Transfert Initiative (ITI) | |
Group | France (govt) | |
Product | TA-46 (Therachon / Pfizer) | |
Product 2 | business development (state/region) | |
Record changed: 2019-05-12 |
Advertisement
More documents for Pfizer (Group)
- [1] Ginkgo Bioworks Inc.. (9/27/23). "Press Release: Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer". Boston, MA....
- [2] AstraZeneca plc. (9/20/23). "Press Release: Alexion Completes Purchase and Licence Agreement for Early-stage Rare Disease Gene Therapy Portfolio from Pfizer"....
- [3] CureVac N.V.. (5/19/23). "Press Release: CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech". Tübingen....
- [4] BioNTech AG. (3/14/23). "Press Release: Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years". New York & Mainz....
- [5] Seagen Inc.. (3/13/23). "Press Release: Pfizer Invests $43 Billion to Battle Cancer. Pfizer to Acquire Seagen for $229 per Seagen Share in Cash". New York, NY & Bothell, WA....
- [6] Tempus Labs, Inc.. (2/28/23). "Press Release: Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development"....
- [7] BioNTech SE. (2/10/23). "Press Release: Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program". New York, NY & Mainz....
- [8] Anokion S.A.. (10/18/22). "Press Release: Anokion Announces $35 Million Equity Investment from Pfizer". Cambridge, MA & Lausanne....
- [9] CytoReason Ltd.. (9/20/22). "Press Release: CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development". Tel Aviv....
- [10] Capstan Therapeutics, Inc.. (9/14/22). "Press Release: Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering". San Diego, CA & Philadelphia, PA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top